Heparan sulfate proteoglycan synthesis and its expression are decreased in the retina of diabetic rats

被引:35
作者
Bollineni, JS [1 ]
Alluru, I [1 ]
Reddi, AS [1 ]
机构
[1] UNIV MED & DENT NEW JERSEY,NEW JERSEY MED SCH,DEPT MED,NEWARK,NJ 07103
关键词
experimental diabetes; retina; heparan sulfate proteoglycan; perlecan; rats;
D O I
10.1076/ceyr.16.2.127.5089
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose. Heparan sulfate proteoglycan (HSPG) is an integral component of all basement membranes and is implicated in the charge-selective properties of these basement membranes. Studies have shown a decrease in the number of HSPG anionic sites in the retinal capillary and glomerular basement membrane of diabetic animals. This study examined whether a decrease in both HSPG synthesis and its expression as perlecan are reduced in the retina of streptozotocin-diabetic rats. Methods. Diabetes was induced in male Wistar rats by intraperitoneal injection of streptozotocin and the rats were sacrificed 20 weeks later. Retinas were isolated and HSPG synthesis was assessed by incorporation of S-35-sulfate into heparan sulfate. The expression of mRNA for perlecan was quantified by RNase protection assay. Results. Both the synthesis of HSPG and mRNA expression for perlecan were decreased in the retina of diabetic compared to normal rats. Conclusions. The decrease in HSPG synthesis may account for the reported decrease in retinal basement membrane anionic sites and increased capillary permeability that occurs in diabetes.
引用
收藏
页码:127 / 130
页数:4
相关论文
共 29 条
[1]   S-35-LABELED GLYCOSAMINOGLYCAN AND S-35-LABELED GLYCOPEPTIDE METABOLISM BY DIABETIC GLOMERULI AND AORTA [J].
BROWN, DM ;
KLEIN, DJ ;
MICHAEL, AF ;
OEGEMA, TR .
DIABETES, 1982, 31 (05) :418-425
[2]  
CALDWELL RB, 1986, INVEST OPHTH VIS SCI, V27, P1691
[3]   ANIONIC SITES IN DIABETIC BASEMENT-MEMBRANES AND THEIR POSSIBLE ROLE IN DIFFUSION BARRIER ABNORMALITIES IN THE BB-RAT [J].
CHAKRABARTI, S ;
MA, N ;
SIMA, AAF .
DIABETOLOGIA, 1991, 34 (05) :301-306
[4]   SINGLE-STEP METHOD OF RNA ISOLATION BY ACID GUANIDINIUM THIOCYANATE PHENOL CHLOROFORM EXTRACTION [J].
CHOMCZYNSKI, P ;
SACCHI, N .
ANALYTICAL BIOCHEMISTRY, 1987, 162 (01) :156-159
[5]  
COHEN MP, 1981, J LAB CLIN MED, V98, P715
[6]   INHIBITION OF FIBRONECTIN BINDING TO MATRIX COMPONENTS BY NONENZYMATIC GLYCOSYLATION [J].
COHEN, MP ;
KU, LN .
DIABETES, 1984, 33 (10) :970-974
[7]   MEDICAL PROGRESS - DISEASES OF THE RETINA [J].
DAMICO, DJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (02) :95-106
[8]   ULTRASTRUCTURAL-LOCALIZATION OF EXTRACELLULAR-MATRIX COMPONENTS IN HUMAN RETINAL-VESSELS AND BRUCHS MEMBRANE [J].
DAS, A ;
FRANK, RN ;
ZHANG, NL ;
TURCZYN, TJ .
ARCHIVES OF OPHTHALMOLOGY, 1990, 108 (03) :421-429
[9]  
*DCCT RES GROUP, 1993, NEW ENGL J MED, V329, P304
[10]  
FRANK RN, 1984, OPHTHALMOLOGY, V91, P626